Somerville, MA, United States of America

Tom Devlin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tom Devlin

Introduction

Tom Devlin is a notable inventor based in Somerville, MA (US). He has made significant strides in the field of formulations and compositions for ortho- and/or retro-nasal delivery. His work focuses on creating compositions that can effectively administer therapeutic substances through innovative delivery methods.

Latest Patents

Tom Devlin holds a patent for "Formulations and compositions for ortho- and/or retro-nasal delivery and associated systems, methods and articles." This patent describes a composition of food or therapeutic substances that can be administered as a cloud of droplets. The droplets have a median size range of approximately 3 microns to 20 microns, or specifically between 5 microns to 10 microns, or 6 microns to 10 microns. The delivery method is designed for introduction to an animal via an ortho-nasal or retro-nasal route. The compositions may include various agonists or antagonists such as sodium iodide, sodium chloride, magnesium chloride, capsaicin, and several others, including flavors and therapeutic agents.

Career Highlights

Tom Devlin is currently associated with Sensory Cloud, where he continues to innovate in the field of aerosol delivery systems. His work has the potential to revolutionize how therapeutic substances are administered, making treatments more effective and accessible.

Collaborations

One of his notable collaborators is David A. Edwards, who shares a vision for advancing delivery systems in the medical and therapeutic fields.

Conclusion

Tom Devlin's contributions to the field of formulations and compositions for nasal delivery highlight his innovative spirit and dedication to improving therapeutic methods. His patent and ongoing work at Sensory Cloud position him as a key figure in the advancement of aerosol delivery technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…